Carnitine supplementation improves insulin sensitivity and skeletal muscle acetylcarnitine formation in patients with type 2 diabetes
Diabetes, Obesity and Metabolism · 2025
DOI: 10.1111/dom.16298 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2025. Verfasst von Yvonne M H Op den Kamp-Bruls und 14 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Radiology and Nuclear Medicine, NUTRIM School for Nutrition and Translational Research in Metabolism, Maastricht University Medical Ce…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Insulin Resistance, Acetylcarnitine, Muscle, Skeletal. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Topconsortium voor Kennis en Innovatie.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aim/Hypothesis Recently, we reported that increasing free carnitine availability resulted in elevated skeletal muscle acetylcarnitine concentrations and restored metabolic flexibility in individuals who have impaired glucose tolerance. Metabolic flexibility is defined as the capacity to switch from predominantly fat oxidation while fasted to carbohydrate oxidation while insulin stimulated. Here we investigated if carnitine supplementation enhances the capacity of skeletal muscle to form acetylcarnitine and thereby improves insulin sensitivity and glucose homeostasis in patients with type 2 diabetes (T2DM).
Methods
Thirty‐two patients followed a 12‐week L‐carnitine treatment (2970 mg/day, orally). Insulin sensitivity was assessed by a two‐step hyperinsulinemic‐euglycemic clamp. In vivo skeletal muscle acetylcarnitine concentrations at rest and post‐exercise (30 min, 70% W max ) and intrahepatic lipid content (IHL) were determined by proton magnetic resonance spectroscopy ( 1 H‐MRS). All measurements were performed before and after 12 weeks of carnitine supplementation.
Results
Compliance with the carnitine supplementation was good (as indicated by increased plasma‐free carnitine levels ( p < 0.01) and pill count (97.1 ± 0.7%)). Insulin‐induced suppression of endogenous glucose production (31.9 ± 2.9 vs. 39.9 ± 3.2%, p = 0.020) and peripheral insulin sensitivity (Δ rate of glucose disappearance (ΔR d ): 10.53 ± 1.85 vs. 13.83 ± 2.02 μmol/kg/min, p = 0.005) improved after supplementation. Resting (1.18 ± 0.13 vs. 1.54 ± 0.17 mmol/kgww, p = 0.008) and post‐exercise (3.70 ± 0.22 vs. 4.53 ± 0.30 mmol/kgww, p < 0.001) skeletal muscle acetylcarnitine concentrations were both elevated after carnitine supplementation. Plasma glucose ( p = 0.083) and IHL ( p = 0.098) tended to be reduced after carnitine supplementation.
Conclusion
Carnitine supplementation improved insulin sensitivity and tended to lower IHL and fasting plasma glucose levels in patients with type 2 diabetes. Furthermore, carnitine supplementation increased acetylcarnitine concentration in muscle, which may underlie the beneficial effect on insulin sensitivity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departments of Radiology and Nuclear Medicine, NUTRIM School for Nutrition and Translational Research in Metabolism, Maastricht University Medical Center, Maastricht, The Netherlands.
- Department of Nutrition and Movement Sciences, NUTRIM School for Nutrition and Translational Research in Metabolism, Maastricht University Medical Center, Maastricht, The Netherlands.
- Laboratory Genetic Metabolic Diseases, Amsterdam Gastroenterology and Metabolism, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands.
- Department of Internal Medicine, Division of Endocrinology, NUTRIM School for Nutrition and Translational Research in Metabolism, Maastricht University Medical Center, Maastricht, The Netherlands.
- Alfasigma Nederland B.V., Utrecht, The Netherlands.
- Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
ORCID-Profile: Esther Phielix, Vera B Schrauwen-Hinderling
Förderung
- Topconsortium voor Kennis en Innovatie
Zitieren
APA
Op den Kamp-Bruls, Y. M. H., Op den Kamp, Y. J. M., Veeraiah, P., Zapata Perez, R., Phielix, E., Havekes, B., Schaart, G., Kornips, E., Berendsen, B. R. B., Virmani, A., Wildberger, J. E., Houtkooper, R. H., Hesselink, M. K. C., Schrauwen, P., & Schrauwen-Hinderling, V. B. (2025). Carnitine supplementation improves insulin sensitivity and skeletal muscle acetylcarnitine formation in patients with type 2 diabetes. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.16298
Vancouver
Op den Kamp-Bruls YMH, Op den Kamp YJM, Veeraiah P, Zapata Perez R, Phielix E, Havekes B, et al. Carnitine supplementation improves insulin sensitivity and skeletal muscle acetylcarnitine formation in patients with type 2 diabetes. Diabetes, Obesity and Metabolism. 2025. doi:10.1111/dom.16298
BibTeX
@article{OpdenKampBruls2025,
author = {Op den Kamp-Bruls, Yvonne M H and Op den Kamp, Yvo J M and Veeraiah, Pandichelvam and Zapata Perez, Ruben and Phielix, Esther and Havekes, Bas and Schaart, Gert and Kornips, Esther and Berendsen, Bart R B and Virmani, Ashraf and Wildberger, Joachim E and Houtkooper, Riekelt H and Hesselink, Matthijs K C and Schrauwen, Patrick and Schrauwen-Hinderling, Vera B},
title = {Carnitine supplementation improves insulin sensitivity and skeletal muscle acetylcarnitine formation in patients with type 2 diabetes},
journal = {Diabetes, Obesity and Metabolism},
year = {2025},
doi = {10.1111/dom.16298}
}
EUVIMED